
|Articles|September 1, 2006
Calculator predicts prognoses in Ta/T1 bladder cancer
Atlanta-A calculator that can instantly predict short-and long-term risks of recurrence and progression in patients with stage Ta/T1 bladder cancer is a few clicks away.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Nicole L. Miller, MD, FACS, on assessing patients after BPH treatment failure
4
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
5











